{"id":"bb46a7de-df4c-51be-8fe0-d7af650d6d1e","stable_key":"7de430a5-1a36-5231-b931-35cc01d8f3bf:apap-the-whole-chain","predicate":"produces","statement":"Systemic 4-aminophenol and 4-hydroxy-3-methoxybenzylamine led to dose-dependent formation of AM404 and of arvanil and olvanil respectively in the mouse brain, the order of potency of these lipid metabolites as TRPV1 activators being arvanil equal to olvanil much greater than AM404, both parent amines displayed antinociceptive activity in rodent pain tests, formation of these metabolites and the antinociceptive effects were substantially reduced or disappeared in fatty acid amide hydrolase null mice, activity was lost in TRPV1 null mice, intracerebroventricular capsazepine eliminated the effects, and in the rat, inhibition of fatty acid amide hydrolase, TRPV1, cannabinoid CB1 receptors and spinal 5-HT3 or 5-HT1A receptors and chemical deletion of bulbospinal serotonergic pathways all prevented the action, giving a pharmacological profile identical to that previously reported for paracetamol.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"positive","is_public":true,"mechanism_event_id":"3bad5114-08d1-5cfa-8a17-f5779c5b729c","mechanism_event_label":"Every step of the proposed chain was cut in turn, and cutting any of them stopped the painkilling.","subject":{"id":"37988be1-ab89-551d-aa24-b4c6b2f655e3","slug":"p-aminophenol","display_name":"4-aminophenol","entity_type_key":"small_molecule"},"object":{"id":"e7864d65-3251-50c8-a6da-083275f96014","slug":"am404","display_name":"AM404 / N-arachidonoylphenolamine","entity_type_key":"small_molecule"},"evidence_count":1,"mechanism_event":{"id":"3bad5114-08d1-5cfa-8a17-f5779c5b729c","stable_key":"7de430a5-1a36-5231-b931-35cc01d8f3bf:apap-the-whole-chain-event","event_type":"biochemical_relationship","label":"Every step of the proposed chain was cut in turn, and cutting any of them stopped the painkilling.","description":"Systemic 4-aminophenol and 4-hydroxy-3-methoxybenzylamine led to dose-dependent formation of AM404 and of arvanil and olvanil respectively in the mouse brain, the order of potency of these lipid metabolites as TRPV1 activators being arvanil equal to olvanil much greater than AM404, both parent amines displayed antinociceptive activity in rodent pain tests, formation of these metabolites and the antinociceptive effects were substantially reduced or disappeared in fatty acid amide hydrolase null mice, activity was lost in TRPV1 null mice, intracerebroventricular capsazepine eliminated the effects, and in the rat, inhibition of fatty acid amide hydrolase, TRPV1, cannabinoid CB1 receptors and spinal 5-HT3 or 5-HT1A receptors and chemical deletion of bulbospinal serotonergic pathways all prevented the action, giving a pharmacological profile identical to that previously reported for paracetamol.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"a4a100bc-130e-5006-bad6-58103aa6da55","slug":"faah","display_name":"Fatty acid amide hydrolase / FAAH","entity_type_key":"protein"},"role":"required_enzyme","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"8e0c61d8-3930-51d5-bce2-25a5edfb797c","slug":"human-trpv1","display_name":"Human transient receptor potential vanilloid 1 / TRPV1","entity_type_key":"protein"},"role":"required_channel","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"d092243c-94e9-5f03-a406-2fa245f2f4ae","slug":"cnr1","display_name":"Human cannabinoid receptor 1 / CB1 / CNR1","entity_type_key":"protein"},"role":"required_receptor","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"6f8e80c7-8a55-58da-b523-30add8133e5c","slug":"bulbospinal-serotonergic-pathway","display_name":"Descending bulbospinal serotonergic pain-suppressing pathways","entity_type_key":"cellular_process"},"role":"required_pathway","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""},{"entity":{"id":"65ba1864-d038-598f-8ac8-4eaa34889202","slug":"spinal-5ht3-receptor","display_name":"Spinal 5-HT3 and 5-HT1A receptors","entity_type_key":"protein_family"},"role":"required_receptor","stoichiometry":null,"state_label":"","sequence_order":4,"notes":""},{"entity":{"id":"b31489f2-5328-50f5-ae31-cbc4d3c159e4","slug":"arvanil","display_name":"Arvanil","entity_type_key":"chemical_species"},"role":"analogous_metabolite","stoichiometry":null,"state_label":"","sequence_order":5,"notes":""},{"entity":{"id":"8a339b5a-a5d3-5091-91ba-0e30d2b15b64","slug":"olvanil","display_name":"Olvanil","entity_type_key":"chemical_species"},"role":"analogous_metabolite","stoichiometry":null,"state_label":"","sequence_order":6,"notes":""},{"entity":{"id":"07e6faf2-ca9c-5fb9-8bca-5e9fab65cb14","slug":"hmba","display_name":"4-hydroxy-3-methoxybenzylamine","entity_type_key":"chemical_species"},"role":"analogous_precursor","stoichiometry":null,"state_label":"","sequence_order":7,"notes":""},{"entity":{"id":"a901be21-7915-543c-ac67-c39ef72b0d03","slug":"acetaminophen","display_name":"Paracetamol","entity_type_key":"drug"},"role":"parent_drug","stoichiometry":null,"state_label":"","sequence_order":8,"notes":""},{"entity":{"id":"37988be1-ab89-551d-aa24-b4c6b2f655e3","slug":"p-aminophenol","display_name":"4-aminophenol","entity_type_key":"small_molecule"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":9,"notes":""},{"entity":{"id":"e7864d65-3251-50c8-a6da-083275f96014","slug":"am404","display_name":"AM404 / N-arachidonoylphenolamine","entity_type_key":"small_molecule"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":10,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/paracetamol-research/23940628.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"cc9d85547497bfdf88095aaeccf5a11cb9198140ebb35523d5da1b85f76e0a44\", \"start_char\": 0, \"end_char\": 2208, \"text_sha256\": \"cc9d85547497bfdf88095aaeccf5a11cb9198140ebb35523d5da1b85f76e0a44\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Metabolite formation and antinociception for 4-aminophenol and a vanillylamine analogue across knockouts and pharmacological blockade","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Systemic 4-aminophenol and 4-hydroxy-3-methoxybenzylamine, with fatty acid amide hydrolase, TRPV1, cannabinoid and serotonergic manipulations","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"The broadest test of the route: it reconstructs the whole chain from metabolite formation to descending pathway, and shows the profile of the metabolite matches that of the parent drug.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Paracetamol research collection; topical membership is not evidence of a direct clinical effect, and the drug is recorded separately from the metabolites NAPQI and AM404.","comparator":null,"unit":null,"notes":"","entity":{"slug":"acetaminophen","display_name":"Paracetamol","entity_type_key":"drug"}},{"dimension":"organism","value_text":"Mouse and rat","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"Every step of the proposed chain was cut in turn, and cutting any of them stopped the painkilling.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[apap-p23940628] Fatty acid amide hydrolase-dependent generation of antinociceptive drug metabolites acting on TRPV1 in the brain. (2013). https://pubmed.ncbi.nlm.nih.gov/23940628/ DOI: 10.1371/journal.pone.0070690","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Brain and spinal cord","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"515ce2db-9912-5907-ba3b-7b01f4d55187","evidence_kind":"source_excerpt","locator":"Lines 324-335","start_line":324,"end_line":335,"excerpt":"### apap-the-whole-chain\nSystemic 4-aminophenol and 4-hydroxy-3-methoxybenzylamine led to dose-dependent formation of AM404 and of arvanil and olvanil respectively in the mouse brain, the order of potency of these lipid metabolites as TRPV1 activators being arvanil equal to olvanil much greater than AM404, both parent amines displayed antinociceptive activity in rodent pain tests, formation of these metabolites and the antinociceptive effects were substantially reduced or disappeared in fatty acid amide hydrolase null mice, activity was lost in TRPV1 null mice, intracerebroventricular capsazepine eliminated the effects, and in the rat, inhibition of fatty acid amide hydrolase, TRPV1, cannabinoid CB1 receptors and spinal 5-HT3 or 5-HT1A receptors and chemical deletion of bulbospinal serotonergic pathways all prevented the action, giving a pharmacological profile identical to that previously reported for paracetamol.\nCondition category: normal\nnutrient_topic: Paracetamol research collection; topical membership is not evidence of a direct clinical effect, and the drug is recorded separately from the metabolites NAPQI and AM404.\nplain_language: Every step of the proposed chain was cut in turn, and cutting any of them stopped the painkilling.\norganism: Mouse and rat\ntissue_or_cell_type: Brain and spinal cord\nexperimental_model: Metabolite formation and antinociception for 4-aminophenol and a vanillylamine analogue across knockouts and pharmacological blockade\nlimitations: The broadest test of the route: it reconstructs the whole chain from metabolite formation to descending pathway, and shows the profile of the metabolite matches that of the parent drug.\nexposure: Systemic 4-aminophenol and 4-hydroxy-3-methoxybenzylamine, with fatty acid amide hydrolase, TRPV1, cannabinoid and serotonergic manipulations\nevidence_span: {\"source_cache\": \"artifacts/paracetamol-research/23940628.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"cc9d85547497bfdf88095aaeccf5a11cb9198140ebb35523d5da1b85f76e0a44\", \"start_char\": 0, \"end_char\": 2208, \"text_sha256\": \"cc9d85547497bfdf88095aaeccf5a11cb9198140ebb35523d5da1b85f76e0a44\"}\n[apap-p23940628] Fatty acid amide hydrolase-dependent generation of antinociceptive drug metabolites acting on TRPV1 in the brain. (2013). https://pubmed.ncbi.nlm.nih.gov/23940628/ DOI: 10.1371/journal.pone.0070690","model_system":"Metabolite formation and antinociception for 4-aminophenol and a vanillylamine analogue across knockouts and pharmacological blockade","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [apap-p23940628] Fatty acid amide hydrolase-dependent generation of antinociceptive drug metabolites acting on TRPV1 in the brain. (2013). https://pubmed.ncbi.nlm.nih.gov/23940628/ DOI: 10.1371/journal.pone.0070690","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"9ee11177-f860-5877-bb82-f4ee4acdc538","stable_key":"import-7de430a5-1a36-5231-b931-35cc01d8f3bf","title":"Paracetamol: the enzyme it reduces rather than blocks, the isoform that turned out not to exist, the metabolite that carries the analgesia, and the metabolite that destroys the liver (2026-09-22)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"9c145887aa10fa7b85f54712e0b41fd9e04fb9544d3182793dd84414dbf8c2ae","revision_id":"c3e7827a-4f10-55e0-97b9-5782b044f7cc","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}